-
11دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574048.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574048Test -
12دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574069.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S4_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574069Test -
13دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574051.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574051Test -
14دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574066.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S5_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574066Test -
15دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574054.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S9_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574054Test -
16دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574057.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S8_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574057Test -
17دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574060.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S7_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574060Test -
18دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574063.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S6_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574063Test -
19دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574072.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S3_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574072Test -
20دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574090.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S12_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574090Test